Network Ad
🛡️ Defense Wire — Military & security news Explore
Loading...
0

Phil Newman of Longevity Technology recently spoke with Dr. Charles Brenner, a leading expert in NAD+ research and the scientist behind the discovery of nicotinamide riboside (NR) as a precursor to NAD+.  Dr. Brenner, currently the chair of the Department of Diabetes and Cancer at City of Hope …

Be respectful and constructive. Comments are moderated.

No comments yet.